India's only pure-play CNS-focused NCE drug discovery company, developing new molecules for Alzheimer's, depression and sleep disorders.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 13 | 13 | 15 | 22 | 22 | 22 | 23 | 26 |
| Reserves | 131 | 95 | 82 | 354 | 248 | 88 | 259 | 565 |
| Borrowings | 6 | 5 | 3 | 2 | 1 | 0 | 0 | 17 |
| Other Liabilities | 33 | 16 | 9 | 12 | 14 | 25 | 56 | 16 |
| Total Liabilities | 182 | 128 | 108 | 389 | 285 | 135 | 337 | 624 |
| AssetsFixed Assets | 25 | 21 | 38 | 37 | 28 | 60 | 58 | 73 |
| CWIP | 0 | 5 | 4 | 0 | 0 | 0 | 1 | 4 |
| Investments | 0 | 0 | 45 | 46 | 76 | 22 | 247 | 181 |
| Other Assets | 157 | 103 | 22 | 305 | 181 | 53 | 32 | 367 |
| Total Assets | 182 | 128 | 108 | 389 | 285 | 135 | 337 | 624 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -53 | -135 | -96 | -128 | -116 | -115 | -154 | -302 |
| Cash from Investing | 30 | 146 | 56 | -22 | -248 | 94 | 155 | -462 |
| Cash from Financing | 5 | 3 | 35 | 146 | 396 | -1 | -1 | 757 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -92 | -137 | -102 | -147 | -119 | -113 | -191 | -307 |
| FCF Margin | — | — | — | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
SUVEN · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.